Not Logged In     Login  
 Release 22.0, Sept. 2008
 
Chapter : ch28. Oncology: Hematologic Section : Acute Lymphoblastic Leukemia (ALL)
  Prognostic Factors in Childhood ALL

  Online Excel Reference
Copyright (c) 2008-2010, Institute for Algorithmic Medicine, Houston, TX, USA. All rights reserved.

Overview :

Identification of significant risk factors in a patient helps in selecting the optimum treatment protocol for that patient, permitting a more or less aggressive approach as needed.

 

Parameters:

(1) age

(2) initial white blood cell count

(3) sex

(4) race

(5) cytogenetics

(6) immunophenotype

(7) FAB morphology

(8) organomegaly

(9) mediastinal mass

(10) lymphadenopathy

(11) hemoglobin

(12) LDL

(13) platelet count

(14) serum immunoglobulins

(15) rapidity of leukemic cytoreduction on induction therapy

(16) response to initial course of induction chemotherapy

 

Parameter

Finding

Prognosis

age

< 12 months

very poor

 

12-23 months

poor (?)

 

2 - 10 years

good

 

> 10 years

poor

initial white blood cell count

> 200,000 per µL

very poor

 

> 50,000 per µL

poor

 

< 10,000

good

sex

females

good

 

males

poor

race

Blacks

poor

cytogenetics

hyperdiploidy (> 50 chromosomes)

good

 

hypoploidy

poor

 

t (8;14)

very poor (induction failure and early relapse)

 

t (9;22) (Philadelphia chromosome)

very poor (induction failure and early relapse)

 

t (4;11)

poor (induction failure and early relapse)

 

dicentric translocation involving short arms of 9 and 12

good

 

t (1;19) and pre-B immunophenotype (not early pre-B)

poor

 

MLL gene rearrangement in infants

very poor

immunophenotype

early pre-B cell (no cytoplasmic immunoglobulin)

good

 

pre-B cell (cytoplasmic immunoglobulin)

poor

 

mature B cell

very poor

 

T cell

poor

 

myeloid markers present

poor

FAB morphology

L3

poor

 

L2

poor

 

L1

good

mediastinal mass

present

poor

organomegaly

hepatomegaly

poor

 

splenomegaly

poor

lymphadenopathy

present

poor

hemoglobin level

 

 

LDH

 

 

platelet count

 

 

serum immunoglobulins

low IgM

poor

 

low IgG and/or IgA

poor

rapidity of leukemic cytoreduction on induction therapy

residual leukemia on day 14 of induction therapy

poor

response to initial course of induction chemotherapy

failure to achieve complete remission

poor

 

where:

• The relationship between initial WBC count and prognosis is linear and continuous, with the prognosis inversely related to the count.

• The worse prognosis in males is related to testicular relapse and the higher rate of T cell ALL.

• The worse prognosis in Blacks is associated with an increased frequency of very high initial white blood cell counts, mediastinal mass, and L2 morphology.

• Mediastinal mass, hepatomegaly, splenomegaly and lymphadenopathy reflect high initial tumor burden and correlation with the initial WBC count.

• > 1,000 blasts per µL one week after preliminary treatment with glucocorticoids and intrathecal methotrexate is a poor prognostic finding (Arico et al)

 

  References:

Arico M, Valsecchi MG, et al. Outcome of treatment in children with Philadelphia chromosome-positive Acute Lymphoblastic Leukemia. N Engl J Med. 2000; 342: 998-1006.

Berg S, Poplack DG. Chapter 68: Clinical manifestations of acute lymphocytic leukemia in children. pages 1067-1075 (Table 68-5, page 1072). IN: Hoffman R, Benz EJ Jr, et al (editors). Hematology, Basic Princples and Practice, Second Edition. Churchill Livingstone. 1995.

Crist W, Pullen J, et al. Acute lymphoid leukemia in adolescents: Clinical and biologic features predict a poor prognosis - A pediatric oncology group study. J Clin Oncology. 1988; 6: 34-43.

Hammond D, Sather H, et al. Analysis of prognostic factors in acute lymphoblastic leukemia. Medical Pediatric Oncology. 1986; 14: 124-134.

Hann IM, Jones PHM, et al. Low IgG or IgA: A further indicator of poor prognosis in childhood acute lymphoblastic leukaemia. Br J Cancer. 1980; 41: 317-319.

Kalwinsky DK, Rivera G, et al. Variation by race in presenting clinical and biologic features of childhood acute lymphoblastic leukaemia: Implications for treatment outcome. Leuk Research. 1985; 9: 817-823.

Khalifa AS, Take H, et al. Immunoglobulins in acute leukemia in children. J Pediatrics. 1974; 85: 788-791.

Leikin S, Miller D, et al. Immunologic evaluation in the prognosis of acute lymphoblastic leukemia. A report from Childrens Cancer Study Group. Blood. 1981; 58: 501-508.

Miller DR. Editor's column: Prognostic factors in childhood leukemia. J Pediatrics. 1975; 87: 672-676.

Pui C-h. Childhood Leukemias. N Engl J Med. 1995; 332: 1618-1630. 1995.

Sather HN. Statistical evaluation of prognostic factors in ALL and treatment results. Medical Pediatric Oncology. 1986; 14: 158-165.

 

 

   Online Excel | Reference TOP
     Pubmed Search For
Copy and paste the article title, or authors names into the search box